Treatment of Lyme Disease
For early Lyme disease with erythema migrans, treat with oral doxycycline 100 mg twice daily or amoxicillin 500 mg three times daily for 14-21 days; for neurologic involvement with parenchymal brain or spinal cord disease, use IV antibiotics; and for Lyme arthritis, use oral antibiotics for 28 days. 1
Early Localized Disease (Erythema Migrans)
First-line oral antibiotic options:
- Doxycycline 100 mg twice daily for 14-21 days 2, 3
- Amoxicillin 500 mg three to four times daily for 14-21 days, with or without probenecid 500 mg three times daily 4, 2
- Cefuroxime axetil as an alternative second-line option 2, 3
Key considerations for early disease:
- Oral therapy is sufficient even for patients with severe early manifestations 4
- Treatment clears signs and symptoms in approximately 90% of patients with relapse rates less than 5% at 6 months 2
- Avoid doxycycline in pregnant women, breastfeeding women, and children under 8 years old due to risk of tooth and bone disorders 2
- Macrolides (azithromycin, clarithromycin, erythromycin) have lower efficacy and should be avoided as first-line agents 2, 3
Neurologic Lyme Disease
For parenchymal brain or spinal cord involvement:
- Use IV antibiotics over oral antibiotics (strong recommendation) 5
- IV ceftriaxone, cefotaxime, or penicillin G for 14-21 days 1
- Oral doxycycline is an alternative for 14-21 days in select cases 1
For acute neurologic presentations requiring testing:
- Meningitis, painful radiculoneuritis, mononeuropathy multiplex, acute cranial neuropathies (particularly VII, VIII), or spinal cord inflammation with epidemiologically plausible tick exposure warrant testing and treatment 5
For isolated facial nerve palsy:
- Oral therapy is usually sufficient if the patient has no other signs or symptoms and normal cerebrospinal fluid 4
- No recommendation exists for or against corticosteroids 5
Lyme Carditis
Outpatient management:
- Oral antibiotics preferred over IV antibiotics for outpatients 5
- Options include doxycycline, amoxicillin, cefuroxime axetil, or azithromycin 5
- Total duration: 14-21 days 5, 1
Inpatient management:
- Initially use IV ceftriaxone until clinical improvement, then switch to oral antibiotics to complete treatment 5
- Admit patients with PR interval >300 milliseconds, other arrhythmias, or clinical manifestations of myopericarditis for continuous ECG monitoring 5
- For symptomatic bradycardia unresponsive to medical management, use temporary pacing rather than permanent pacemaker implantation 5
Clinical indicators for ECG monitoring:
- Perform ECG only in patients with symptoms consistent with Lyme carditis: dyspnea, edema, palpitations, lightheadedness, chest pain, syncope, exercise intolerance, presyncope, pericarditic pain, elevated troponin, or shortness of breath 5
Lyme Arthritis
Treatment approach:
- Use oral antibiotic therapy for 28 days (strong recommendation) 5, 1
- Oral amoxicillin or doxycycline are first-line options 3
For partial response after first course:
- Mild residual joint swelling after initial treatment: no clear recommendation exists for second course versus observation 5
- Consider excluding other causes of joint swelling, assess medication adherence, and evaluate duration of arthritis prior to initial treatment 5
For treatment failure:
- No or minimal response may require IV ceftriaxone for 2-4 weeks 6
Post-Treatment Management: Critical Decision Algorithm
Step 1: Assess for objective signs of active disease
- Objective findings required: arthritis with documented joint swelling and effusion, meningitis with CSF abnormalities, neuropathy with objective neurologic findings, or carditis with documented conduction abnormalities 6
Step 2: If only nonspecific symptoms present
- Do NOT prescribe additional antibiotics for persistent fatigue, pain, or cognitive impairment without objective evidence of reinfection or treatment failure (strong recommendation) 5, 6, 1
- Treatment failure rate with appropriate initial therapy is approximately 1%; cure rate is approximately 99% 6
Step 3: Interpret serology correctly
- Never treat based on positive IgM serology alone without objective clinical findings 6
- IgM antibodies commonly persist for months or years after successful treatment and do not indicate ongoing infection 6
- Serologic testing cannot distinguish between past treated infection and active disease 6
Common Pitfalls to Avoid
- Do not routinely test for Lyme disease in patients with psychiatric illness, developmental/behavioral disorders, typical ALS, relapsing-remitting MS, Parkinson's disease, dementia, cognitive decline, or new-onset seizures 5
- Do not prescribe prolonged or unending courses of antibiotics for noninfectious problems such as fibromyalgia that may persist after treatment 4
- Do not confuse persistent antibodies with persistent infection 6
- Routine antibiotic prophylaxis after tick bite is not justified even in endemic areas, as infection risk is low 2